Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Estimated value
—
Awarded value
—
Suppliers
38
Lots
1
Published
12 Jan 2026
Description
Generic, Branded Generic & Proprietary Medicinal Products - Group 17 (6067696)
Scope
- Reference
- 6067696
- Commercial tool
- Standalone contract
- Contract dates
It is likely that most contracts awarded using the DPS will be renewed for purposes of continued supply. The product range of each contract may, however, change on each renewal. Some contracts may be restructured, merged, divided or no longer required.
- Main category
- goods
- Contract locations
- Northern Ireland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Award Criteria (Eligibility Envelope): Compliance with Contract Scope and Specification | Pass/Fail | quality | — |
| Award Criteria (Eligibility Envelope): Supply and Delivery of Product (i) (Evidence of Compliance with Good Distribution Practice (GDP) Requirements, as outlined in the Contract Scope and Specification) | Pass/Fail | quality | — |
| Award Criteria (Eligibility Envelope): Supply and Delivery of Product (ii) (Evidence of compliance with the Medical Device supply / EU Authorised Representative requirements as outlined in the Contract Scope and Specification) | Pass/Fail | quality | — |
| Award Criteria (Eligibility Envelope): Registration on the NHS Evergreen Sustainable Supplier Assessment platform, as outlined in the Contract Scope and Specification) | Pass/Fail | quality | — |
| Award Criteria (Technical Envelope): Supply and Delivery of Product (Same Working Day Delivery) | 5% | quality | — |
| Award Criteria (Technical Envelope): Supply and Delivery of Product (Wholesale Distribution) | 5% | quality | — |
| Award Criteria (Technical Envelope): Continuity of Supply (Minimum Committed Stockholding) | 8% | quality | — |
| Award Criteria (Eligibility Envelope): Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA) Section 1 | Pass/Fail | quality | — |
| Award Criteria (Technical Envelope): Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA) Section 2 - Section 6 | 40% | quality | — |
| — | 42% | price | — |
Submission & procedure
- Procedure
- Restricted procedure
Award details· 38 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Award 1· 1 supplier
Awarded —
Award 2· 1 supplier
Awarded —
Award 3· 1 supplier
Awarded —
Award 4· 1 supplier
Awarded —
Award 5· 1 supplier
Awarded —
Award 6· 1 supplier
Awarded —
Award 7· 1 supplier
Awarded —
Award 8· 1 supplier
Awarded —
Award 9· 1 supplier
Awarded —
Award 10· 1 supplier
Awarded —
Award 11· 1 supplier
Awarded —
Award 12· 1 supplier
Awarded —
Award 13· 1 supplier
Awarded —
Award 14· 1 supplier
Awarded —
Award 15· 1 supplier
Awarded —
Award 16· 1 supplier
Awarded —
Award 17· 1 supplier
Awarded —
Award 18· 1 supplier
Awarded —
Award 19· 1 supplier
Awarded —
Award 20· 1 supplier
Awarded —
Award 21· 1 supplier
Awarded —
Award 22· 1 supplier
Awarded —
Award 23· 1 supplier
Awarded —
Award 24· 1 supplier
Awarded —
Award 25· 1 supplier
Awarded —
Award 26· 1 supplier
Awarded —
Award 27· 1 supplier
Awarded —
Award 28· 1 supplier
Awarded —
Award 29· 1 supplier
Awarded —
Award 30· 1 supplier
Awarded —
Award 31· 1 supplier
Awarded —
Award 32· 1 supplier
Awarded —
Award 33· 1 supplier
Awarded —
Award 34· 1 supplier
Awarded —
Award 35· 1 supplier
Awarded —
Award 36· 1 supplier
Awarded —
Award 37· 1 supplier
Awarded —
Award 38· 1 supplier
Awarded —
Other contracts from Procurement and Logistics Service, Business Services Organisation
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Accord Uk Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide | contract | — | 26 Mar 2026 |
| Generic Drugs – Injections/Infusions 2 | contract | — | 03 Mar 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 25 Feb 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 26 Nov 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 11 Nov 2025 |